en · de · es · fr · pt
melanotan-2-notes.peptides4800.com › Wiki › Handling, Storage, And Analytical Verification — Explained

Handling, Storage, And Analytical Verification — Explained

By Editorial Desk · published 2025-09-21 · last reviewed 2025-10-20 · Wiki

If you have been reading about MC1R and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.

Last reviewed on 2025-10-20. Where a claim depends on a specific study, the study is described rather than over-claimed.

Handling, Storage, and Analytical Verification

Regulatory treatment varies by country. In the United States the peptide is not approved as a medicine, and products offered for human use may be treated as unapproved new drugs; some states also restrict sale. Australia, the United Kingdom, and European Union member states apply comparable restrictions to unapproved peptide products. Border agencies have seized shipments labelled as research chemicals. Classification may change over time, and the legal position for personal importation is not clearly settled in most published guidance.

Lyophilised melanotan-2 is supplied as a solid, which is more stable than a solution. The material is hygroscopic, so weighing is done quickly, in low humidity, with the container kept sealed. Reconstitution usually uses water for injection or bacteriostatic water, added down the wall of the vial to limit foaming. A reconstituted solution is held at 2 to 8 °C and kept away from light. Repeated freezing and thawing of the same vial is avoided because ice crystal formation and concentration effects degrade the peptide.

Reversed-phase high-performance liquid chromatography is the routine method for purity assessment. Peptides absorb near 214 nm because of the peptide bond, and a gradient of acetonitrile in water separates the intact peptide from deletion sequences, oxidised products, and earlier-eluting fragments at neutral pH. Electrospray ionisation mass spectrometry provides an orthogonal check: the measured mass must agree with the theoretical value. Amino acid analysis and peptide mapping confirm structure but are used less often. Reference standards remain scarce because the peptide is not described in any pharmacopoeia.

Chemical Background and Receptor Activity

Melanotan-2 is frequently confused with afamelanotide, a linear analogue authorised in the European Union for erythropoietic protoporphyria. The two compounds differ in chain length, ring structure and receptor selectivity, so findings for one cannot be transferred directly to the other. Published controlled human data on melanotan-2 remain sparse, and much of what circulates online derives from small studies or unpublished reports. Questions about effect size, dose-response behaviour and long-term safety therefore remain unresolved.

Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence incorporates a lactam bridge that constrains the peptide into a ring, which increases resistance to enzymatic breakdown relative to the natural hormone. Researchers at the University of Arizona synthesised the compound in the late 1980s and early 1990s while studying pigmentation pathways. It has never received marketing approval from any national medicines regulator. In the scientific literature it is usually described as a laboratory research reagent rather than a therapeutic product.

The peptide acts as a non-selective agonist at melanocortin receptors, showing affinity for MC1R, MC3R, MC4R and MC5R. Activation of MC1R on melanocytes drives the conversion of tyrosine into melanin and shifts production toward the darker eumelanin form. MC4R signalling in the central nervous system is linked to appetite and energy balance, which helps explain why reduced food intake appeared in early human studies. Effects on MC4R and on vascular tone also account for the erectile responses recorded as unexpected findings in those same trials.

Melanotan-2 at a glance

PropertyValueNotes
Lyophilised storage−20 °C, dry, protected from lightVials are sealed and allowed to reach room temperature before opening
Reconstituted storage2 to 8 °C, protected from lightShort-term holding; avoid repeated freeze-thaw cycles
Reconstitution solventWater for injection or bacteriostatic waterAdded slowly along the vial wall to reduce foaming and shear
Purity measurementRP-HPLC with area normalisationAcetonitrile-water gradient monitored at roughly 214 nm
Identity confirmationElectrospray ionisation mass spectrometryObserved mass compared against the calculated peptide mass

Regulatory Status and Literature Discussion

Reported observations after unregulated use include shifts in skin pigmentation and, in some accounts, unintended changes to moles and other lesions. Whether these outcomes are causally linked to the compound, and how often they occur, remain open questions because controlled data are scarce. The absence of standardised dosing and verified product purity complicates interpretation. Researchers have called for better surveillance and analytical characterisation of samples obtained outside regulated channels. Conclusions drawn from anecdotal evidence should be treated as provisional.

Melanotan-2 has not received marketing authorisation from major regulatory agencies for any therapeutic indication. Several jurisdictions classify it as a prescription-only medicine or a controlled substance when supplied for human use. Because approved products do not exist, material sold online usually sits outside pharmaceutical supply chains and formal quality oversight. Regulators have issued public notices describing the compound as unapproved. Enforcement varies, and the legal position differs between countries, which complicates any single general statement about its status.

Scientific discussion of Melanotan-2 spans pharmacology, dermatology, and public-health literature. Laboratory studies examine its receptor binding and cellular effects, while clinical reports describe outcomes observed after unregulated use. These two bodies of work differ in rigour and intent. Peer-reviewed trials of the compound as a medicine are limited, so much of the available information comes from case reports and surveillance data. Authors frequently note the gap between experimental findings and real-world use.

Related pages on this site

Chemistry and Receptor Pharmacology

Receptor-binding studies classify melanotan II as a non-selective melanocortin agonist. It interacts with MC1R, MC3R, MC4R and MC5R, with reported affinities in the low nanomolar range and no strong subtype preference. Activation of MC1R on dermal melanocytes shifts pigment synthesis toward eumelanin, the dark polymer deposited in melanosomes and transferred to keratinocytes. Because the same peptide engages MC4R in the hypothalamus, it also appears in animal work on food intake and erectile response, which is why it is discussed in both pigment and metabolic research. Which receptor populations dominate after systemic exposure in humans is not fully established.

Published pharmacokinetic information is limited and comes mainly from small studies rather than registrational trials. Plasma half-life is usually described as short, on the order of tens of minutes, followed by rapid tissue distribution and clearance of the intact peptide. Metabolites and low concentrations of parent compound have been reported in urine, a detail relevant to anti-doping and forensic testing. Whether repeated exposure changes receptor sensitivity or clearance over time remains an open question. Values differ noticeably between analytical assays, so published numbers should be read as approximate rather than definitive.

Melanotan II is a synthetic cyclic heptapeptide with the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, corresponding to a molecular formula of C50H69N15O9 and a monoisotopic mass near 1024 daltons. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, a peptide hormone produced by cleavage of proopiomelanocortin. A lactam bridge between the aspartate and lysine side chains closes the ring, and the C-terminal amide removes a free carboxyl group. Both modifications increase resistance to enzymatic degradation compared with the linear parent hormone. Four substitutions distinguish it from afamelanotide, the linear analogue studied under the name melanotan I.

Handling, Storage and Analytical Control

Melanotan-2 is handled in the laboratory as a lyophilised powder that dissolves readily in water, dimethyl sulfoxide and dimethylformamide, with limited solubility in ethanol. Stock solutions prepared in an organic solvent often precipitate when diluted into aqueous buffer, so gradual dilution with mixing is standard practice. The peptide carries a tryptophan residue and a histidine residue, both sensitive to oxidation and to alkaline conditions. Working solutions are therefore kept near neutral to slightly acidic pH, protected from light, and consumed within the same working session whenever that is practical.

Solid peptide kept dry at minus twenty degrees Celsius, shielded from light and moisture, is generally considered stable for extended periods. Solutions are divided into single-use aliquots and held at minus twenty or minus eighty degrees Celsius, because repeated freeze-thaw cycles promote aggregation and loss of material to container surfaces. Hydrolysis of the backbone and oxidation of tryptophan are the principal degradation routes in aqueous solution, and both accelerate at ambient temperature. Hygroscopic uptake after a vial is opened can also shift the actual mass weighed, which affects any concentration calculated from it.

Melanotan II Background and Mechanism

Melanotan II is a synthetic cyclic heptapeptide that acts as an agonist at melanocortin receptors. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous peptide involved in pigment production. The analogue carries a lactam bridge that constrains the ring and slows enzymatic breakdown relative to the native hormone. In research literature it appears under several abbreviations, and naming conventions are not fully standardized. Published descriptions usually place it within the broader melanocortin agonist family.

Receptor binding at MC1R on melanocytes raises intracellular cyclic AMP and increases expression of tyrosinase and related enzymes. The downstream result is greater synthesis of eumelanin, the dark pigment, without ultraviolet exposure acting as the trigger. The compound is not selective, however, and also engages MC3R, MC4R and MC5R, which are expressed in the central nervous system and elsewhere. That lack of selectivity is the explanation usually offered for effects reported outside pigmentation, including appetite suppression and nausea. Selectivity remains a central theme in comparative studies of related peptides.

Human data remain limited and mostly short-term. Reports describe small trials and observational accounts rather than large controlled studies, so questions about dose-response relationships and long-term effects on melanocytes stay open. Whether repeated exposure alters naevus behaviour is not settled in the published record. Researchers also note that self-administered use outside clinical settings makes actual exposure difficult to quantify. Statements about efficacy and safety should therefore be read as preliminary rather than established.

Supporting material

Brachyury, Axl, MEK, and Aurora kinase A are molecular drivers of these programs, and inhibitors are currently in clinical trials to determine therapeutic applications. Oncogenic PKC-iota can promote melanoma cell invasion by activating Vimentin during EMT. PKC-iota inhibition or knockdown resulted an increase E-cadherin and RhoA levels while decreasing total Vimentin, phosphorylated Vimentin (S39) and Par6 in metastatic melanoma cells. These results suggested that PKC-ι is involved in signaling pathways which upregulate EMT in melanoma. EMT has been indicated to be involved in acquiring drug resistance. Gain of EMT markers was found to be associated with the resistance of ovarian carcinoma epithelial cell lines to paclitaxel. Similarly, SNAIL also confers resistance to paclitaxel, adriamycin and radiotherapy by inhibiting p53-mediated apoptosis. Furthermore, inflammation, that has been associated with the progression of cancer and fibrosis, was recently shown to be related to cancer through inflammation-induced EMT. Consequently, EMT enables cells to gain a migratory phenotype, as well as induce multiple immunosuppression, drug resistance, evasion of apoptosis mechanisms. Some evidence suggests that cells that undergo EMT gain stem cell-like properties, thus giving rise to Cancer Stem Cells (CSCs). Upon transfection by activated Ras, a subpopulation of cells exhibiting the putative stem cell markers CD44high/CD24low increases with the concomitant induction of EMT.

GTP = 3′,5′-cyclic GMP + diphosphate It is often part of the G protein signaling cascade that is activated by low intracellular calcium levels and inhibited by high intracellular calcium levels. In response to calcium levels, guanylate cyclase synthesizes cGMP from GTP. cGMP keeps cGMP-gated channels open, allowing for the entry of calcium into the cell. Like cAMP, cGMP is an important second messenger that internalizes the message carried by intercellular messengers such as peptide hormones and nitric oxide and can also function as an autocrine signal. Depending on cell type, it can drive adaptive/developmental changes requiring protein synthesis. In smooth muscle, cGMP is the signal for relaxation, and is coupled to many homeostatic mechanisms including regulation of vasodilation, vocal tone, insulin secretion, and peristalsis. Once formed, cGMP can be degraded by phosphodiesterases, which themselves are under different forms of regulation, depending on the tissue.

12 July – Members of the NASUWT teaching union in England vote to stage strike action over pay, with 85.5% of members voting to do so on a 51.9% turnout. 13 July – Data released by NHS England indicates that 7.47 million people were waiting to begin routing hospital treatment in June 2023, an increase from 7.42 million in May. The UK government proposes a 6.5% pay rise for teachers, with the leaders of all four major teaching unions expressing support for the increase, meaning strikes by teachers in England are likely to end. Pradjeet Veadhasa, 17, and Sukhman Shergill, 17, are sentenced to life imprisonment with minimum terms of 18 and 16 years respectively for the June 2022 murder of 16-year-old Ronan Kanda in Wolverhampton, who they stabbed after mistaking him for an enemy. 14 July – The UK Health Security Agency warns that tens of thousands of cases of measles could potentially occur in London because of low vaccination numbers there. A 65-year-old man is charged with the murders of Naomi Hunte, who was stabbed to death in February 2022, and Fiona Holm, who disappeared in June 2023 and whose body has not been found. The UK government approves plans to build a road tunnel near Stonehenge. Following trial and conviction at Portsmouth Crown Court, Sarah Somerton-How and her lover, George Webb, are both sentenced to 11 years imprisonment for wilful neglect and holding a person in slavery or servitude after they kept Somerton-How's husband, who has cerebral palsy and is severely sight impaired, a prisoner in squalid conditions for four years.

==== Application ==== Some of the applications of these CSPs include the direct chiral analysis of β-adrenergic blockers such as metoprolol and celiprolol, the calcium channel blocker, felodipine and the anticonvulsant agent, ethotoin.

=== Ocean dumping of radioactive waste === Between 1969 and 1982, conditioned low- and intermediate-level radioactive waste was disposed of in the Atlantic Ocean at a depth of about 4,000 meters under the supervision of the Nuclear Energy Agency (NEA) of the Organization for Economic Cooperation and Development (OECD) in accordance with the provisions of the European Convention on the Prevention of Marine Pollution by Dumping of Waste of All Kinds (London Dumping Convention of June 11, 1974). This was carried out jointly by several European countries. Since 1993, international treaties have prohibited the dumping of radioactive waste in the oceans. For decades, this dumping of nuclear waste went largely unnoticed by the public until Greenpeace denounced it in the 1980s.

Sources: en.wikipedia.org

Supporting material

Apothecia (fruiting bodies) are rare in Parmotrema perlatum. When present, they measure 4–8 mm across and are somewhat stalked and funnel-shaped with a brown, concave disc. The edges of these structures curl inward, becoming thick with soredia as they mature. Its spores are ellipsoid in shape and typically measure between 20 and 28 μm in length and 11 to 17 μm in width, with a wall thickness of 2–3 μm. Pycnidia, which are structures that produce asexual spores called conidia, appear sporadically on the surface (laminal) of the thallus, with the conidia being thread-like and straight, measuring 6–8 by 1 μm.

AM-1235 metabolism differs only slightly from that of JWH-018. AM-1235 N-dealkylation produces 1-fluoropentane instead of pentane or other simple alkanes in general. It had been speculated that the fluoropentane might function as an alkylating agent or be further metabolized into toxic fluoroacetic acid. This is not true, however, as fluoroalkanes do not act as alkylating agents under normal conditions and odd-length fluoroalkane chains metabolize into substantially less toxic fluoropropanoic acid.

9 January – Séamus Begley, 73, traditional musician and singer. 16 January Carrie Acheson, 88, politician, TD (1981–1982). Joe Martin, 91, footballer (Dundalk, League of Ireland XI). 18 January – John L. Murray, 79, jurist, chief justice (2004–2011), judge of the Supreme Court (1999–2015) and the ECJ (1992–1999). 19 January Bertie Cunningham, 83, Gaelic footballer (Ballivor, Meath senior team). Peter Thomas, 78, footballer (Waterford, Galway United, national team). Born in England. 20 January – Pierce Higgins, 45, hurler (Tooreen, Ballyhaunis, Mayo senior team), motor neuron disease. 21 January – Micheál Mac Gréil, 91, Jesuit priest, sociologist and writer. 30 January – Eddie Spence, 97, Gaelic footballer (Belfast O'Connell's, Antrim senior team). Born in Northern Ireland. 31 January – Donie Hanlon, 85, Gaelic footballer (Gracefield, Offaly senior team).

== Other uses == Caldwell 8 (NGC 559), an open cluster in Cassiopeia Celestron, 8-inch (200 mm) a Schmidt-Cassegrain telescope C8 carbine, an assault rifle used by Canada and other NATO forces made by Diemaco/Colt Canada C8 Unemployment Indemnity (Shipwreck) Convention, 1920 Elbrus-8C, a Russian 28 Nanometre 8 core microprocessor An international standard paper size (57×81 mm), defined in ISO 216

== H == habitat – HACEK organism – halobacteria – haploid – Hardy–Weinberg principle – heart – Hela cell – helper T cell – Hepadnaviridae – hepatitis B – herbivore – heredity – hereditary disease – hermaphrodite – herpetology – Hershey–Chase experiment – heterochromatin – heterotroph – heterozygote – Hfr cell – hibernation – hierarchy of life – Hill reaction – His tag – histone – homeobox – homeostasis – homologous recombination – homology – homoplasy – homozygote – homunculus – horizontal gene transfer – hormone – host – household gene – human – Human Genome Project – humoral immunity – hybrid (biology) – hybridization – hydrolysis – hydrolytic enzyme – hygiene – hyperpolarization (biology)

Sources: en.wikipedia.org

Supporting material

Glomerular filtration of unbound drug. Active secretion of (free & protein-bound) drug by transporters (e.g. anions such as urate, penicillin, glucuronide, sulfate conjugates) or cations such as choline, histamine. Filtrate 100-fold concentrated in tubules for a favorable concentration gradient so that it may be secreted by passive diffusion and passed out through the urine.

Primary: Sodium thiopental, 5 grams, intravenous Secondary: Midazolam, 10 mg, intramuscular; sufentanil, 450 micrograms, intramuscular; and/or hydromorphone, 40 mg, intramuscular In the brief for the U.S. courts written by accessories, the State of Ohio implies that they were unable to find any physicians willing to participate in the development of protocols for executions by lethal injection, as this would be a violation of medical ethics, such as the Geneva Promise, and such physicians would be thrown out of the medical community and shunned for engaging in such deeds, even if they could not lawfully be stripped of their license. On December 8, 2009, Kenneth Biros became the first person executed using Ohio's new single-drug execution protocol. He was pronounced dead at 11:47 am EST, 10 minutes after receiving the injection. On September 10, 2010, Washington became the second state to use the single-drug Ohio protocol with the execution of Cal Coburn Brown, who was proclaimed dead within two minutes after receiving the single-drug injection of sodium thiopental. Eight states (Arizona, Georgia, Idaho, Missouri, Ohio, South Dakota, Texas, and Tennessee) have used the single-drug execution protocol. The state of Washington used this single drug method only once, as it later abandoned the death penalty. Four additional states (Arkansas, Kentucky, Louisiana, and North Carolina) announced that they would switch to a single-drug protocol but, as of June 2025, had not executed anyone since switching protocols.

However, it must not be confused with the traditional Asturian cider as it is a sparkling cider more in the way of French ciders. It is a factory produced cider, sweet and very foamy, much like lambrusco, different from the more artisan and traditional cider productions. Recently, new apple tree plantations have been started in grounds belonging to the old coal mines, once important in Asturias.

Topiramate is used to treat epilepsy in children and adults, and it was originally used as an anticonvulsant. In children, it is indicated for the treatment of Lennox-Gastaut syndrome, a disorder that causes seizures and developmental delay. It is most frequently prescribed for the prevention of migraines, as it decreases the frequency of attacks. Topiramate is used to treat medication overuse headache and is recommended by the European Federation of Neurological Societies as one of the few medications showing effectiveness for this indication.

Sources: en.wikipedia.org

Frequently asked questions

Why are freeze-dried peptides kept cold?

Low temperature slows hydrolysis and oxidation, the two main routes by which the peptide backbone and side chains are modified. A lyophilised powder stored at −20 °C is more stable than one kept at room temperature, and once the material is dissolved the degradation rate rises, making refrigeration more important.

How is sample identity confirmed?

Liquid chromatography coupled to mass spectrometry is the most common approach because it combines a retention time with a mass measurement. A chromatographic peak alone cannot establish which peptide is present, so mass determination or amino acid analysis is used as an orthogonal confirmation alongside the separation.

How long can a reconstituted solution be kept?

This depends on buffer, pH, and concentration, and published stability data for this peptide are limited. In practice laboratories work through a refrigerated solution within a few weeks and discard samples that show cloudiness or visible particles. Freezing and thawing repeatedly is generally discouraged.

What class of compound is melanotan-2?

It is a synthetic cyclic heptapeptide modelled on alpha-melanocyte-stimulating hormone. A lactam bridge links two side chains, forming a ring that stabilises the molecule against proteolysis. It belongs to the broader melanocortin peptide family.

Network